Endocrinol Metab.  2015 Sep;30(3):381-388. 10.3803/EnM.2015.30.3.381.

Sumoylation of Hes6 Regulates Protein Degradation and Hes1-Mediated Transcription

Affiliations
  • 1Department of Brain and Cognitive Sciences, Seoul National University School of Biological Sciences, Seoul, Korea. kyungjin@dgist.ac.kr
  • 2Department of Legal Medicine, Korea University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Hes6 is a transcriptional regulator that induces transcriptional activation by binding to transcription repressor Hes1 and suppressing its activity. Hes6 is controlled by the ubiquitin-proteosome-mediated degradation system. Here we investigated the sumoylation of Hes6 and its functional role in its rhythmic expression.
METHODS
Hes6, SUMO, and ubiquitin were transfected into HeLa cells and the expression pattern was observed by Western blot and immunoprecipitation. To confirm the effect of sumoylation on the rhythmic expression of Hes6, we generated mouse Hes6 promoter-driven GFP-Hes6 fusion constructs and expressed these constructs in NIH 3T3 cells.
RESULTS
Overexpression of SUMO led to sumoylation of Hes6 at both lysine 27 and 30. Protein stability of Hes6 was decreased by sumoylation. Moreover, expression of a Hes6 sumoylation-defective mutant, the 2KR (K27/30R) mutant, or co-expression of SUMO protease SUSP1 with native Hes6, strongly reduced ubiquitination. In addition, sumoylation was associated with both the rhythmic expression and transcriptional regulation of Hes6. Wild type Hes6 showed oscillatory expression with about 2-hour periodicity, whereas the 2KR mutant displayed a longer period. Furthermore, sumoylation of Hes6 derepressed Hes1-induced transcriptional repression.
CONCLUSION
Hes6 sumoylation plays an important role in the regulation of its stability and Hes1-mediated transcription. These results suggest that sumoylation may be crucial for rhythmic expression of Hes6 and downstream target genes.

Keyword

Hes6; Sumoylation; Ubiquitination; Degradation; Rhythmic expression

MeSH Terms

Animals
Blotting, Western
HeLa Cells
Humans
Immunoprecipitation
Lysine
Mice
NIH 3T3 Cells
Periodicity
Protein Stability
Proteolysis*
Repression, Psychology
Sumoylation*
Transcriptional Activation
Ubiquitin
Ubiquitination
Lysine
Ubiquitin

Figure

  • Fig. 1 Sumoylation of Hes6. (A) HeLa cells were co-transfected with Hes6 and RFP-SUMO paralogues (SUMO1 or SUMO3) in the presence or absence of Ubc9. Samples were analyzed by Western blot using anti-Hes6 antibodies. (B) Hes6, RFP-SUMO, and Ubc9 were co-expressed in cells and the cell extracts were subjected to immunoprecipitation followed by Western blot using anti-Hes6, anti-SUMO1, or anti-SUMO3 antibodies. Arrowheads indicate the sumoylated Hes6 (black) or native Hes6 (white) band.

  • Fig. 2 Hes6 is sumoylated at lysine residues 27 and 30. (A) Proteins were extracted from HeLa cells transfected with Hes6 constructs encoding wild type (WT) or its Lys-Arg mutants. Western blot was performed with the indicated antibodies. (B) Cells were transfected with Hes6 constructs encoding WT, the single mutants (K27R or K30R), or the 2KR (K27/30R) double mutant together with SUMO and Ubc9 and analyzed by Western blot using anti-Hes6 antibodies.

  • Fig. 3 Sumoylation promotes ubiquitination of Hes6. (A) HeLa cells expressing wild type (WT) Hes6 or the 2KR (K27/30R) double mutant were treated with cychloheximide (CHX, 30 µg/mL) for indicated time periods. The protein abundance of Hes6 was analyzed by Western blot using anti-Hes6 antibodies and then quantitated by densitometer. (B) Cells were co-transfected with WT Hes6 or the 2KR mutant and HA-tagged ubiquitin (Ub) in the presence or absence of RFP-SUMO and SUSP1 and incubated for 5 hours with 25 µM MG132. Cell extracts were analyzed by immunoprecipitation followed by Western blot using anti-HA, anti-SUMO, or anti-Hes6 antibodies.

  • Fig. 4 Sumoylation regulates rhythmic expression of Hes6. (A) The schematic diagram of GFP-fused wild type (WT) or the 2KR (K27/30R) mutant Hes6 under the control of the Hes6 promoter. (B) NIH 3T3 cells were transfected with GFP-Hes6 constructs encoding WT or the 2KR mutant. After serum treatment (t=0), Hes6 protein levels were examined every 30 minutes.

  • Fig. 5 Effects of Hes6 sumoylation on Hes1-induced transcriptional suppression. (A) HeLa cells were co-transfected with pHes1-luciferase reporter, Hes1 (20 ng), and increasing amounts of Hes6 (50, 100, 200, and 300 ng). After overnight incubation, the bioluminescence was measured using a luminometer. Each value is the mean±SEM of three independent experiments. (B) Cells were co-transfected with the pHes1-luciferase reporter, Hes1, and Hes6 (wild type [WT] or the 2KR [K27/30R] mutant). Each value is the mean±SEM of three independent experiments (P<0.001). (C) Cells were co-transfected with Hes1 and Hes6 and the cell lysates were immunoprecipitated using anti-Hes1 antibodies. (D) Chromatin was extracted from HeLa cells transfected with Hes1 and Hes6 constructs encoding WT or the 2KR mutant. Chromatin immunoprecipitation (ChIP) assays were performed with the indicated antibodies. aP<0.001 vs. Hes1 expression; bP<0.001.


Reference

1. Bertrand N, Castro DS, Guillemot F. Proneural genes and the specification of neural cell types. Nat Rev Neurosci. 2002; 3:517–530.
2. Ross SE, Greenberg ME, Stiles CD. Basic helix-loop-helix factors in cortical development. Neuron. 2003; 39:13–25.
3. Kageyama R, Ohtsuka T, Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development. 2007; 134:1243–1251.
4. Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S. Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev. 1992; 6:2620–2634.
5. Chen H, Thiagalingam A, Chopra H, Borges MW, Feder JN, Nelkin BD, et al. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci U S A. 1997; 94:5355–5360.
6. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signalling downstream of activated mammalian Notch. Nature. 1995; 377:355–358.
7. Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J. 1999; 18:2196–2207.
8. Bae S, Bessho Y, Hojo M, Kageyama R. The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation. Development. 2000; 127:2933–2943.
9. Koyano-Nakagawa N, Kim J, Anderson D, Kintner C. Hes6 acts in a positive feedback loop with the neurogenins to promote neuronal differentiation. Development. 2000; 127:4203–4216.
10. Harima Y, Imayoshi I, Shimojo H, Kobayashi T, Kageyama R. The roles and mechanism of ultradian oscillatory expression of the mouse Hes genes. Semin Cell Dev Biol. 2014; 34:85–90.
11. Pascoal S, Carvalho CR, Rodriguez-Leon J, Delfini MC, Duprez D, Thorsteinsdottir S, et al. A molecular clock operates during chick autopod proximal-distal outgrowth. J Mol Biol. 2007; 368:303–309.
12. Schwendinger-Schreck J, Kang Y, Holley SA. Modeling the zebrafish segmentation clock's gene regulatory network constrained by expression data suggests evolutionary transitions between oscillating and nonoscillating transcription. Genetics. 2014; 197:725–738.
13. Masamizu Y, Ohtsuka T, Takashima Y, Nagahara H, Takenaka Y, Yoshikawa K, et al. Real-time imaging of the somite segmentation clock: revelation of unstable oscillators in the individual presomitic mesoderm cells. Proc Natl Acad Sci U S A. 2006; 103:1313–1318.
14. Shimojo H, Ohtsuka T, Kageyama R. Oscillations in notch signaling regulate maintenance of neural progenitors. Neuron. 2008; 58:52–64.
15. Hirata H, Yoshiura S, Ohtsuka T, Bessho Y, Harada T, Yoshikawa K, et al. Oscillatory expression of the bHLH factor Hes1 regulated by a negative feedback loop. Science. 2002; 298:840–843.
16. Hirata H, Bessho Y, Kokubu H, Masamizu Y, Yamada S, Lewis J, et al. Instability of Hes7 protein is crucial for the somite segmentation clock. Nat Genet. 2004; 36:750–754.
17. Bessho Y, Sakata R, Komatsu S, Shiota K, Yamada S, Kageyama R. Dynamic expression and essential functions of Hes7 in somite segmentation. Genes Dev. 2001; 15:2642–2647.
18. Takebayashi K, Sasai Y, Sakai Y, Watanabe T, Nakanishi S, Kageyama R. Structure, chromosomal locus, and promoter analysis of the gene encoding the mouse helix-loop-helix factor HES-1. Negative autoregulation through the multiple N box elements. J Biol Chem. 1994; 269:5150–5156.
19. Kang SA, Seol JH, Kim J. The conserved WRPW motif of Hes6 mediates proteasomal degradation. Biochem Biophys Res Commun. 2005; 332:33–36.
20. Hay RT. SUMO: a history of modification. Mol Cell. 2005; 18:1–12.
21. Chiou HY, Liu SY, Lin CH, Lee EH. Hes-1 SUMOylation by protein inhibitor of activated STAT1 enhances the suppressing effect of Hes-1 on GADD45alpha expression to increase cell survival. J Biomed Sci. 2014; 21:53.
22. Denuc A, Marfany G. SUMO and ubiquitin paths converge. Biochem Soc Trans. 2010; 38(Pt 1):34–39.
23. Schimmel J, Larsen KM, Matic I, van Hagen M, Cox J, Mann M, et al. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics. 2008; 7:2107–2122.
24. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell. 1998; 2:233–239.
25. Lee J, Lee Y, Lee MJ, Park E, Kang SH, Chung CH, et al. Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex. Mol Cell Biol. 2008; 28:6056–6065.
26. Cardone L, Hirayama J, Giordano F, Tamaru T, Palvimo JJ, Sassone-Corsi P. Circadian clock control by SUMOylation of BMAL1. Science. 2005; 309:1390–1394.
27. Kageyama R, Ohtsuka T, Kobayashi T. Roles of Hes genes in neural development. Dev Growth Differ. 2008; 50:Suppl 1. S97–S103.
28. Lee YJ, Han DH, Pak YK, Cho SH. Circadian regulation of low density lipoprotein receptor promoter activity by CLOCK/BMAL1, Hes1 and Hes6. Exp Mol Med. 2012; 44:642–652.
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr